(Total Views: 418)
Posted On: 06/12/2024 6:04:32 PM
Post# of 148889
Taking this process, now applying Ai to it currently?
Dr. J recently said he's looked for 5 yrs for a combo drug regiment, for once a month injectiction.
Cytodyn has stated 180 day success.
Isn't it Gilead who just announced trial for 1 injection, over 180 days?
______________
July 29, 2015
Furthermore, our ongoing manufacturing activities to produce future Phase 3 and commercial PRO 140 material has resulted in identifying processes which have doubled the yield, thereby potentially reducing future manufacturing costs by as much as 50%."
"This process could not have been so successful without the strong leadership of our chairman of the board, Anthony Caracciolo, former senior vice president of manufacturing for Gilead Sciences, Inc.,"
https://www.biospace.com/article/releases/cyt...hase-iii-/
______________
All pretty ironic timing of events.
Somebody mentioned either Cytodyn was muscled out of the gender HIV, or we're working with them.
My bet would be with.
None of these sub-par drugs gives pharma the muscle to stop LL, now with hold lifted.
Combined with an always over-looked fact of FDA has zero influence over the Patent Office, & there's no turning back now against LL.
From any, entity or ghost entity.
& yep, seemingly-harmless, FDA recently approving drugs that kill & other serious Warnings, is outstanding for Cytodyn.
FDA has now legally locked themselves into giving LL recognition, on proven esults.
As trial results warrant special FDA designations & approval(s), they will be given.
FDA sees LL's power & has exited any future "fight", LL can bring, to any pharma company.
They know there's change coming & lifting hold was them wiping their hands clean of past & future.
Shall see....
Dr. J recently said he's looked for 5 yrs for a combo drug regiment, for once a month injectiction.
Cytodyn has stated 180 day success.
Isn't it Gilead who just announced trial for 1 injection, over 180 days?
______________
July 29, 2015
Furthermore, our ongoing manufacturing activities to produce future Phase 3 and commercial PRO 140 material has resulted in identifying processes which have doubled the yield, thereby potentially reducing future manufacturing costs by as much as 50%."
"This process could not have been so successful without the strong leadership of our chairman of the board, Anthony Caracciolo, former senior vice president of manufacturing for Gilead Sciences, Inc.,"
https://www.biospace.com/article/releases/cyt...hase-iii-/
______________
All pretty ironic timing of events.
Somebody mentioned either Cytodyn was muscled out of the gender HIV, or we're working with them.
My bet would be with.
None of these sub-par drugs gives pharma the muscle to stop LL, now with hold lifted.
Combined with an always over-looked fact of FDA has zero influence over the Patent Office, & there's no turning back now against LL.
From any, entity or ghost entity.
& yep, seemingly-harmless, FDA recently approving drugs that kill & other serious Warnings, is outstanding for Cytodyn.
FDA has now legally locked themselves into giving LL recognition, on proven esults.
As trial results warrant special FDA designations & approval(s), they will be given.
FDA sees LL's power & has exited any future "fight", LL can bring, to any pharma company.
They know there's change coming & lifting hold was them wiping their hands clean of past & future.
Shall see....
(2)
(0)Scroll down for more posts ▼
